Cough, Cold and Allergy (Hay Fever) Remedies in Estonia
COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES IN ESTONIA
Euromonitor International
February 2019
LIST OF CONTENTS AND TABLES
Headlines
Prospects
Cough, Cold and Allergy (hay Fever) Remedies Remains A Seasonal Product
Unit Price Stability Is A Key Factor in Value Performance
Flu Season and New Product Developments Influence Growth
Competitive Landscape
Established Brands Lead Sales
Competition Pushes Producers To Look for New Options
International Players Dominate Cough, Cold and Allergy (hay Fever) Remedies
Category Data
Table 1 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2013-2018
Table 2 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2013-2018
Table 3 NBO Company Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2014-2018
Table 4 LBN Brand Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2015-2018
Table 5 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2018-2023
Table 6 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2018-2023
Executive Summary
Consumer Health Grows Despite Fewer Changes in Trends and Regulations
Development Starts To Slow As Some Categories Approach Maturity
Although Leading Players Maintain Positions, Market Becomes More Fragmented
Chemists/pharmacies Remains the Main Distribution Channel
Declining Consumer Base and Increasing Competition Is Expected
Market Indicators
Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2013-2018
Table 8 Life Expectancy at Birth 2013-2018
Market Data
Table 9 Sales of Consumer Health by Category: Value 2013-2018
Table 10 Sales of Consumer Health by Category: % Value Growth 2013-2018
Table 11 NBO Company Shares of Consumer Health: % Value 2014-2018
Table 12 LBN Brand Shares of Consumer Health: % Value 2015-2018
Table 13 Distribution of Consumer Health by Format: % Value 2013-2018
Table 14 Distribution of Consumer Health by Format and Category: % Value 2018
Table 15 Forecast Sales of Consumer Health by Category: Value 2018-2023
Table 16 Forecast Sales of Consumer Health by Category: % Value Growth 2018-2023
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventive Medicine
Switches
Summary 1 OTC: Switches
Definitions
Sources
Summary 2 Research Sources
Cough, cold and allergy (hay fever) remedies remained dependent on the flu season by nature and this is expected to remain the core factor behind its performance over the forecast period. Although governments try to increase vaccination against the flu, most Estonians had a high level of scepticism regarding flu vaccines. The vaccines bought and subsidised by the government do not always comply with the type of flu that is prevalent in any particular year. This was the case in 2017/2018 when the...
Euromonitor International's Cough, Cold and Allergy (Hay Fever) Remedies in Estonia report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2014-2018, allowing you to identify the sectors driving growth. Forecasts to 2023 illustrate how the market is set to change.
Product coverage: Antihistamines/Allergy Remedies (Systemic), Combination Products - Cough, Cold and Allergy (Hay Fever) Remedies, Cough Remedies, Decongestants, Medicated Confectionery, Paediatric Cough, Cold and Allergy Remedies, Pharyngeal Preparations.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
* Get a detailed picture of the Cough, Cold and Allergy (Hay Fever) Remedies market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.
Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.